Sight Sciences, Inc.

NASDAQ:SGHT

Medical - Devices

Healthcare
$10.77 +2.89%

+$0.15 today

Market cap
$598.59M
Beta
2.40
P/E (TTM)
-7.5
EPS (TTM)
-$0.69
52W Low $3.11High $9.24

Volume 0.34M

Average 0.25M

SGHT Total Current Liabilities

All obligations due within one year.

Sight Sciences, Inc.NASDAQ: SGHT

Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total current liabilities rises 49.8% from a year ago

Total current liabilities stood at $18.16M at the end of Q1 FY2026, up 49.8% from a year earlier and up 64.7% from the prior quarter. Over 3 fiscal years it compounded at -14.8% a year.

Context

  • Total current liabilities amounted to 16.6% of total assets at the end of Q1 FY2026, up 7.2 pp from a year earlier.
  • Total current liabilities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total current liabilities keeps rising in the next quarterly balance sheet after a +49.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$18.16M+64.7% QoQ
Last fiscal yearDec 2025
$11.03M-28.7% YoY
Year agoMar 2025
$12.12M+49.8% since
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+49.8%——
1 year-28.7%——
3-year CAGR-14.8%——
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

USD · from the balance sheet

Latest · FY2025
11.03M USD
Year-over-year change
-28.7%
4-year CAGR
-4.9%

Total Current Liabilities vs competitors

How SGHT compares with its peers on the latest reported figures

  • SGHT's Mar 2026 total current liabilities of $18.16M is the 6th highest of the 7 companies compared; the peer median is $96.88M.
  • Its year-over-year change of +49.8% is the highest of 6, against a peer median of -6.5%.
  • Total current liabilities amounts to 16.6% of total assets for SGHT, versus a peer median of 10.0%.
SGHT Competitors Peer median
Total Current Liabilities for SGHT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BHCBausch Health Companies Inc.Jun 2026$4.54B -8.7%+1.9%18.3%
ALCAlcon Inc.Sep 2026$2.79B -6.5%+3.7%8.9%
GKOSGlaukos CorporationJun 2026$102.33M +29.3%+11.9%11.1%
HROWHarrow Health, Inc.Mar 2026$91.44M -51.1%+72.9%21.8%
OCULOcular Therapeutix, Inc.Mar 2026$47.68M +25.7%+17.4%6.5%
SGHTSight Sciences, Inc.Mar 2026$18.16M +49.8%-14.8%16.6%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$6.67M ——2.6%
Peer median (excluding SGHT) $96.88M-6.5%+11.9%10.0%

Competitors are the stored peer set for SGHT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents260.69M185M138.13M120.36M91.97M
Short-term Investments00000
Net Receivables8.71M15.15M14.29M10.79M9.75M
Inventory3.48M6.11M7.85M6.33M7.77M
Other Current Assets13.42M2.6M2.31M3.26M
Total Current Assets277.04M209.68M162.87M139.77M112.73M
Property, Plant & Equipment (Net)2.95M3.19M3.1M2.52M2.05M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets202K211K682K550K518K
Total Non-current Assets3.15M3.4M3.78M3.07M2.57M
Total Assets280.19M213.07M166.65M142.84M115.3M
Account Payables3.35M2.69M1.73M1.69M1.34M
Short-term Debt002.22M00
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities5.99M7.35M4.53M9.68M6.07M
Total Current Liabilities13.5M17.82M12.25M15.47M11.03M
Long-term Debt32.66M33.31M31.71M39.36M40.3M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities879K1.23M1.56M19K31K
Total Non-current Liabilities34.58M35.18M34.18M39.85M40.33M
Total Liabilities48.08M53M46.44M55.32M51.36M
Common Stock48K48K49K51K54K
Retained Earnings(153M)(239.24M)(294.79M)(346.3M)(384.72M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity232.11M160.08M120.22M87.52M63.94M
Total Debt34.21M34.98M35.41M40.36M40.78M
Net Debt(226.48M)(150.02M)(102.72M)(80M)(51.19M)

Sight Sciences, Inc.

NASDAQ:SGHT

Intrinsic Alpha fair value

Locked

Current Price

$10.77

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.